140 related articles for article (PubMed ID: 37027834)
1. Expert Consideration on Regulatory Aspects for Perinatal Derivatives in Clinical Settings.
Hofmann N; Lafarge X; Antica M; Ferry N; Girandon L; Gramignoli R; Jurga M; Kerdjoudj H; Navakauskiene R; Schiavi J; Shablii V; Nicolás FJ; Gindraux F
Stem Cells Transl Med; 2023 May; 12(5):258-265. PubMed ID: 37027834
[TBL] [Abstract][Full Text] [Related]
2. Perinatal derivatives application: Identifying possibilities for clinical use.
Gindraux F; Hofmann N; Agudo-Barriuso M; Antica M; Couto PS; Dubus M; Forostyak S; Girandon L; Gramignoli R; Jurga M; Liarte S; Navakauskiene R; Shablii V; Lafarge X; Nicolás FJ
Front Bioeng Biotechnol; 2022; 10():977590. PubMed ID: 36304904
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. EU Water Framework Directive and Stockholm Convention: can we reach the targets for priority substances and persistent organic pollutants?
Fuerhacker M
Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S92-7. PubMed ID: 19337768
[TBL] [Abstract][Full Text] [Related]
5. Expert Revision of Key Elements for Clinical-Grade Production and Qualification of Perinatal Derivatives.
Gramignoli R; Hofmann N; Agudo-Barriuso M; Antica M; Flores AI; Girandon L; Kerdjoudj H; Navakauskiene R; Schiavi J; Scholz H; Shablii V; Lafarge X; Nicolás FJ; Gindraux F
Stem Cells Transl Med; 2024 Jan; 13(1):14-29. PubMed ID: 38071447
[TBL] [Abstract][Full Text] [Related]
6. General consensus on multimodal functions and validation analysis of perinatal derivatives for regenerative medicine applications.
Pozzobon M; D'Agostino S; Roubelakis MG; Cargnoni A; Gramignoli R; Wolbank S; Gindraux F; Bollini S; Kerdjoudj H; Fenelon M; Di Pietro R; Basile M; Borutinskaitė V; Piva R; Schoeberlein A; Eissner G; Giebel B; Ponsaerts P
Front Bioeng Biotechnol; 2022; 10():961987. PubMed ID: 36263355
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Prospects of Advanced Therapy Medicinal Products-Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives.
Bakopoulou A
J Endod; 2020 Sep; 46(9S):S175-S188. PubMed ID: 32950189
[TBL] [Abstract][Full Text] [Related]
9. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
Beattie S;
Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
[TBL] [Abstract][Full Text] [Related]
10. "Eurocode International Blood Labeling System" enables unique identification of all biological products from human origin in accordance with the European Directive 2004/23/EC.
Knels R; Mönig HJ; Wittmann G; von Versen R; Pruss A
Cell Tissue Bank; 2010 Nov; 11(4):345-52. PubMed ID: 20563859
[TBL] [Abstract][Full Text] [Related]
11. Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States.
Iglesias-Lopez C; Obach M; Vallano A; Agustí A
Cytotherapy; 2021 Mar; 23(3):261-274. PubMed ID: 33483292
[TBL] [Abstract][Full Text] [Related]
12. Regulatory landscape for cell therapy--EU view.
McBlane JW
Biologicals; 2015 Sep; 43(5):433-6. PubMed ID: 25997566
[TBL] [Abstract][Full Text] [Related]
13. From the Integrity of Potency Assays to Safe Clinical Intervention: Legal Perspectives.
Roslin W; Mansnérus J
Adv Exp Med Biol; 2023; 1420():151-163. PubMed ID: 37258789
[TBL] [Abstract][Full Text] [Related]
14. Guidelines to Analyze Preclinical Studies Using Perinatal Derivatives.
Pires AS; Bollini S; Botelho MF; Lang-Olip I; Ponsaerts P; Balbi C; Lange-Consiglio A; Fénelon M; Mojsilović S; Berishvili E; Cremonesi F; Gazouli M; Bugarski D; Gellhaus A; Kerdjoudj H; Schoeberlein A
Methods Protoc; 2023 Apr; 6(3):. PubMed ID: 37218905
[TBL] [Abstract][Full Text] [Related]
15. Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?
Boráň T; Menezes-Ferreira M; Reischl I; Celis P; Ferry N; Gänsbacher B; Krafft H; Lipucci di Paola M; Sladowski D; Salmikangas P
Hum Gene Ther Clin Dev; 2017 Sep; 28(3):126-135. PubMed ID: 28510497
[TBL] [Abstract][Full Text] [Related]
16. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Foffi G; Pastore A; Piazza F; Temussi PA
Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review of the Application of Perinatal Derivatives in Animal Models on Cutaneous Wound Healing.
Pichlsberger M; Jerman UD; Obradović H; Tratnjek L; Macedo AS; Mendes F; Fonte P; Hoegler A; Sundl M; Fuchs J; Schoeberlein A; Kreft ME; Mojsilović S; Lang-Olip I
Front Bioeng Biotechnol; 2021; 9():742858. PubMed ID: 34631683
[TBL] [Abstract][Full Text] [Related]
18. Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems.
Pirnay JP; Vanderkelen A; De Vos D; Draye JP; Rose T; Ceulemans C; Ectors N; Huys I; Jennes S; Verbeken G
Cell Tissue Bank; 2013 Dec; 14(4):525-60. PubMed ID: 24052113
[TBL] [Abstract][Full Text] [Related]
19. Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell Nomenclature.
Silini AR; Di Pietro R; Lang-Olip I; Alviano F; Banerjee A; Basile M; Borutinskaite V; Eissner G; Gellhaus A; Giebel B; Huang YC; Janev A; Kreft ME; Kupper N; Abadía-Molina AC; Olivares EG; Pandolfi A; Papait A; Pozzobon M; Ruiz-Ruiz C; Soritau O; Susman S; Szukiewicz D; Weidinger A; Wolbank S; Huppertz B; Parolini O
Front Bioeng Biotechnol; 2020; 8():610544. PubMed ID: 33392174
[TBL] [Abstract][Full Text] [Related]
20. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
